JN AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Neurophysiol (August 16, 2006). doi:10.1152/jn.00287.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/6/3538    most recent
00287.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lasztoczi, B.
Right arrow Articles by Kardos, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lasztoczi, B.
Right arrow Articles by Kardos, J.
Submitted on March 16, 2006
Accepted on August 15, 2006

Cyclothiazide Prolongs Low-[Mg2+]-Induced Seizure-Like Events

Balint Lasztoczi1* and Julianna Kardos1

1 Department of Neurochemistry, Institute of Biomolecular Chemistry, Chemical Research Center, Hungarian Academy of Sciences, Budapest, Hungary

* To whom correspondence should be addressed. E-mail: laszto{at}chemres.hu.

Here we address the effects of cyclothiazide (CTZ), an allosteric inhibitor of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor desensitization, on low-[Mg2+]-induced seizure-like events (SLEs) recorded from the CA3 pyramidal layer of juvenile rat hippocampal slices. CTZ (100 µM) made the period of tonic-like discharges (161 ± 18 % of control) and the whole SLE (151 ± 15 % of control) longer (in 7 out of 9 slices), or induced endless SLE by stabilizing clonic-like bursting (in 2 out of 9 slices). 30 µM CTZ had no significant effects on SLE dynamics (N=4), while 300 µM CTZ induced endless SLEs in 4 out of 8 slices. Co-application of CTZ (100 µM) with 100 µM GYKI 52466, the allosteric inhibitor of AMPA receptor function restrained the effects of CTZ and shortened SLEs and their tonic phases to 37 ± 4.2 % and 47 ± 4.2 % of the control, respectively. Effects of GYKI-52466 and GYKI-52466 with CTZ on SLE dynamics were indistinguishable. 50 µM 4-aminopyridine (4-AP) alone (N=5) or in combination with CTZ (N=6) transformed recurrent SLE pattern into incessant epileptiform activity with patterns distinguishable from those under 100 µM CTZ application. The effect of 4-AP may suggest a role for facilitated presynaptic glutamate release in disrupting recurrent dynamics. In contrast, the self-similar slow-down of low-[Mg2+]-induced SLE dynamics by CTZ indicate AMPA receptor desensitization as a parameter shaping SLEs.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the The American Physiological Society.